MEI Pharma, Inc..
MEIP.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
MEI Pharma, Inc. is a pharmaceutical company focused on the development of novel cancer therapies. The company's pipeline includes clinical-stage drug candidates targeting various hematologic malignancies and solid tumors. Their research and development efforts are primarily directed towards discove...Show More
Better Health for All
-20
MEI Pharma's core business is entirely devoted to health improvement, focusing on developing novel drug candidates for cancer therapies, specifically voruciclib and ME-344, which target resistance mechanisms in acute myeloid leukemia and metastatic colorectal cancer.
1
The company's entire product pipeline is dedicated to addressing these serious health conditions. Research and development expenses, which represent the company's investment in health innovation, were $52.5 million in fiscal year 2023, a decrease from $85.6 million in fiscal year 2022, attributed to the wind-down of zandelisib activities.
2
In terms of safety, a clinical study evaluating ME-344 in combination therapy reported that the treatment was generally well-tolerated.
3
However, two out of 23 patients (approximately 8.7%) discontinued therapy due to adverse events (fatigue and sepsis).
4
Common adverse events included fatigue (35% overall, 13% Grade 3/4) and abdominal pain (13% overall, 9% Grade 3/4).
5
Fair Money & Economic Opportunity
0
No evidence available to assess MEI Pharma, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess MEI Pharma, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
20
Corrective action plans for complaints, non-conformances, recalls, or deviations are completed within three business days.
1
No specific quantitative data is provided for fair trade certifications, audit frequency, forced or child labor incidents, traceability coverage, ethical clause coverage, high-risk materials spend, or supplier diversity spend.
2
Honest & Fair Business
-40
MEI Pharma has a whistleblower policy
1
and an anti-corruption policy
2
, but specific details regarding their strength, enforcement, or effectiveness, such as hotline usage or training frequency, are not provided. The board of directors includes five independent members out of six, representing approximately 83% of the board.
3
The company's financial statements for the fiscal year ended June 30, 2024, were audited by Deloitte & Touche LLP
4
, providing third-party verification of financial claims
5
, but the percentage of revenue, assets, or subsidiaries covered is not explicitly stated.
Kind to Animals
-50
MEI Pharma conducts animal testing, specifically pre-clinical trials on animals, including mice, for drug candidates like ME-344.
1
The company's policy is to comply with FDA regulations and ICH guidance regarding animal welfare.
2
Annually, the company uses between 10,000 and 15,000 animals in testing.
No War, No Weapons
0
No evidence available to assess MEI Pharma, Inc. on No War, No Weapons.
Planet-Friendly Business
-20
The company's ESG summaries and sustainability reports do not mention any specific regulatory actions, violations, fines, or compliance issues.
1
Respect for Cultures & Communities
0
No evidence available to assess MEI Pharma, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
10
Lite Strategy Inc. (formerly MEI Pharma) holds EU-U.S., UK Extension to the EU-U.S., and Swiss-U.S. Data Privacy Framework (DPF) certifications.
1
There are no documented incidents of unauthorized data use.
2
The company provides users with strong control over their personal data, including the ability to opt-out of communications, request changes or deletion of data, and exercise rights under European and state privacy laws, with requests addressed within 30 days.
3
Lite Strategy retains personal data only for the length of time required to fulfill the purpose for which it was collected, with cookie data retained for 1 year and unsuccessful job applicant data for the duration of the hiring process unless consent is given.
4
The company demonstrates good compliance with applicable regulations, including GDPR and CCPA, and uses Standard Contractual Clauses for international data transfers.
5
Zero Waste & Sustainable Products
0
No evidence available to assess MEI Pharma, Inc. on Zero Waste & Sustainable Products.